Seth B Forman MD

Dermatology•Tampa, FL

Dermatologic Surgery, Dermatopathology

Physician

Join to View Full Profile

15416 North Florida AvenueTampa, FL 33613
Phone+1 813-960-2400
Fax+1 813-960-2410

Summary

Dr. Seth Forman is a dermatologist in Tampa, FL and is affiliated with multiple hospitals in the area, including BayCare and AdventHealth Tampa. He received his medical degree from Virginia Commonwealth University School of Medicine and has been in practice 15 years. He specializes in dermatopathology and is experienced in dermatopathology.

Education & Training

Geisinger Health SystemFellowship, Dermatopathology, 2006 - 2007
Virginia Commonwealth University Health SystemResidency, Dermatology, 2003 - 2006
Virginia Commonwealth University Health SystemInternship, Internal Medicine, 2002 - 2003
Virginia Commonwealth University School of MedicineClass of 2002

Certifications & Licensure

FL State Medical License 2006 - 2027
PA State Medical License 2006 - 2007
VA State Medical License 2002 - 2006
American Board of Dermatology Dermatology
American Board of Dermatology Dermatopathology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011

Clinical Trials

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo Start of enrollment: 2017 Jun 07
Completed
Phase 2
A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis Start of enrollment: 2017 Apr 12
Completed
Phase 1
Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa Start of enrollment: 2019 Feb 27
ACTIVE_NOT_RECRUITING
PHASE2
Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum Start of enrollment: 2019 May 16
Completed
Phase 2
A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa Start of enrollment: 2019 Sep 16
Completed
Phase 2
A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032 Start of enrollment: 2019 Sep 24
TERMINATED
PHASE2
Join now to see all

Publications & Presentations

PubMed

A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2-11 Years with Moderate to Severe Atopic Dermatitis.
Linda Stein Gold, Robert Bissonnette, Seth Forman, Andrea Zaenglein, YuTzu Kuo
American Journal of Clinical Dermatology. 2025-03-01
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysi...
Melissa Piliang, Charles Lynde, Brett King, Paradi Mirmirani, Rodney Sinclair
Journal of the American Academy of Dermatology. 2025-02-01
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial.
Eric L Simpson, Lawrence F Eichenfield, Kim A Papp, Seth B Forman, Adelaide A Hebert
Dermatitis. 2025-01-10

Press Mentions

Tampa Doctor Seeks Tenants for $6.7 Million Medical Office ProjectAugust 29th, 2024
Response Rates in Hidradenitis Suppurativa Continue to Climb with New TherapiesMarch 20th, 2023
'Better Than Surgery': Electron Beam Therapy New Option for Skin Cancer Patients at Tampa Doctor's OfficeOctober 6th, 2021
Join now to see all